Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human neutrophil collagenase.

H E Van Wart1

  • 1Department of Chemistry, Florida State University, Tallahassee 32306.

Matrix (Stuttgart, Germany). Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Human neutrophil collagenase (HNC) was purified from neutrophils, revealing distinct active and latent forms. This enzyme preferentially degrades Type I collagen, offering insights into neutrophil-mediated tissue remodeling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.

Bioorganic & medicinal chemistry letters·2003
Same author

Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates.

Bioorganic & medicinal chemistry letters·2003
Same author

Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues.

Bioorganic & medicinal chemistry letters·2001
Same author

Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase.

Bioorganic & medicinal chemistry letters·2000
Same author

Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).

Arthritis and rheumatism·2000
Same author

Comparison of the peroxidase reaction kinetics of prostaglandin H synthase-1 and -2.

The Journal of biological chemistry·1999
Same journal

Studies on purified neutral proteoglycan-degrading enzyme (stromelysin/matrix metalloproteinase 3) from human articular cartilage.

Matrix (Stuttgart, Germany). Supplement·1992
Same journal

The small matrix metalloproteinase of the rat uterus.

Matrix (Stuttgart, Germany). Supplement·1992
Same journal

Literature on vertebrate matrix metalloproteinases and their tissue inhibitors.

Matrix (Stuttgart, Germany). Supplement·1992
Same journal

Nomenclature and glossary of the matrix metalloproteinases.

Matrix (Stuttgart, Germany). Supplement·1992
Same journal

Plasmin activation of collagenase during ovulation in the perfused rat ovary.

Matrix (Stuttgart, Germany). Supplement·1992
Same journal

Inhibition of ovulation in the perfused rat ovary by a synthetic collagenase inhibitor.

Matrix (Stuttgart, Germany). Supplement·1992
See all related articles

Area of Science:

  • Biochemistry
  • Enzymology
  • Cell Biology

Background:

  • Human neutrophil collagenase (HNC) plays a role in tissue remodeling.
  • HNC exists in latent and active forms with varying molecular weights (58-75 kDa).
  • Stabilization during purification is crucial due to HNC's sensitivity.

Purpose of the Study:

  • To describe the purification of different HNC forms.
  • To investigate the activation patterns of latent HNC.
  • To characterize the substrate specificity and properties of HNC.

Main Methods:

  • Purification of HNC from buffy coats and neutrophil exudates.
  • Use of protease inhibitors and antioxidants for stabilization.
  • Activation studies using trypsin, organomercurials, and oxidants.

Related Experiment Videos

  • Collagenase activity assays and octapeptide hydrolysis examination.

    • Main Results:

    • Successfully purified active and latent 58 kDa HNC forms with high yield and specific activity.
    • Demonstrated preferential hydrolysis of Type I collagen over Types II and III.
    • Identified HNC as a glycoprotein containing complex N-linked oligosaccharides.
    • Characterized activation patterns of latent HNC species.

    Conclusions:

    • Developed a robust protocol for HNC purification, yielding highly active enzyme.
    • HNC exhibits specific collagenolytic activity, primarily targeting Type I collagen.
    • HNC's glycoprotein nature suggests potential roles in post-translational modifications and interactions.